You are here: Home Newsroom Features Study shows how community pharmacy can provide a better patient experience for anticoagulation monitoring

Study shows how community pharmacy can provide a better patient experience for anticoagulation monitoring

09 February 2018
Feature Healthcare

Latest work from Boots UK and the University of Brighton has demonstrated that community pharmacy is ideally placed to provide a safe anticoagulation service for patients needing warfarin monitoring, delivering enhanced clinical outcomes and patient experience.

Published recently in the journal BMC Health Services Research, the evaluation tracked over 2,000 patients on warfarin who were using the Community Pharmacy Anticoagulation Management Service between 2009 and 2016 in Brighton and Hove. Previously, these patients would have needed to attend regular hospital outpatient clinics to have blood samples taken to assess their International Normalised Ratio (INR) readings, but now are able to access this service from their local community pharmacy, improving patient convenience along with accessibility of the service.

Patient outcomes were shown to exceed targets for patients using the service (percentage INR readings in therapeutic range (65.4%) and percentage time in therapeutic range (72.5%), versus targets of 60% and 70% respectively). The study also showed high levels of patient satisfaction with the service, with over 98.6% of patients rating the service as good, very good or excellent.

Marc Donovan, Chief Pharmacist at Boots UK said: “Anticoagulation management continues to evolve rapidly, and using learnings from studies such as this helps to find opportunities where services can also adapt. As a pharmacy-led service, the community setting can increase patient access to professional advice and testing, ultimately leading to improved INR control.

“This study is important in demonstrating the role that community pharmacy has and continues to have in adapting to meet the changing need of patients, and supports the commissioning of key services from primary care settings.”

Samantha Ingram, Boots Teacher Practitioner at the University of Brighton, said: “Anticoagulants are essential for helping prevent blood clots and our collaborative research showed that providing this service at local community pharmacies proved practicable and helpful for patients.”

The study ran after Brighton and Hove Clinical Commissioning Group made the decision to shift this service from the secondary care setting into local community pharmacies.

James Morton, Commissioning Manager – Urgent and Community, Brighton and Hove Clinical Commissioning Group, said: “The Community Pharmacy Anticoagulation Management Service has proven consistently popular with our patients, by providing accessible clinics closer to home rather than having to travel to attend a hospital appointment.  Recent innovations such as piloting self-testing for a specific cohort of patients have further enhanced patient experience, particularly for people who work.  Brighton and Hove’s GP’s also highly value the service and it provides an invaluable bridge between primary and secondary care services.”

Pharmacists are well placed to take on the role of practitioner in this field as their knowledge of drug interactions, pharmaceutical products, pharmacokinetic principles and counselling skills enables them to effectively manage patients safely within agreed treatment protocols.

The full report is available here:


What’s new at Boots? Find out the latest updates from the UK’s largest pharmacy-led health and beauty chain – from new products and services to important business developments.



Read the views of our team members at Boots, who are experts in their field. Find out what they think about the most important issues of the day – from healthcare equality to sustainability.


Media Resources

A you are a journalist looking for information and resources about Boot? Visit our media resources hub to access images, reports, spokespeople and videos.


Boots is the UK’s leading health and beauty retailer with over 52,000 team members and 2,100 stores, ranging from local community pharmacies to large destination health and beauty stores.*

Boots serves its customers and patients for life as the leading provider of healthcare on the high street and the UK’s number one beauty destination. It offers an unrivalled depth and breadth of products, which incorporates its extensive own brand range and innovative portfolio of brands, including No7, the UK’s No1 skincare brand, Soap & Glory, Liz Earle Beauty and Sleek MakeUP.

2024 marks Boots’ 175th anniversary year. Founder John Boot opened a herbalist store in Nottingham in 1849 to offer an affordable alternative to traditional medicines. His son Jesse expanded the business to become a modern retailer and the biggest chemist in Britain. Throughout its history, Boots has listened, learned and innovated, and it continues to challenge itself to improve its products and services every day.

Boots is part of Walgreens Boots Alliance, which is a global leader in pharmacy-led, health and wellbeing retail.  More company information is available on

*Figures accurate as of 30 November 2023